DE69802828D1 - Verwendung von 6,7-substituierter 2-aminotetraline zur behandlung von zytokin-vermittleten entzündungszuständen - Google Patents
Verwendung von 6,7-substituierter 2-aminotetraline zur behandlung von zytokin-vermittleten entzündungszuständenInfo
- Publication number
- DE69802828D1 DE69802828D1 DE69802828T DE69802828T DE69802828D1 DE 69802828 D1 DE69802828 D1 DE 69802828D1 DE 69802828 T DE69802828 T DE 69802828T DE 69802828 T DE69802828 T DE 69802828T DE 69802828 D1 DE69802828 D1 DE 69802828D1
- Authority
- DE
- Germany
- Prior art keywords
- substituted
- aminotetraline
- cytokin
- flammability
- mediated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT97RM000569A IT1294932B1 (it) | 1997-09-22 | 1997-09-22 | Uso di 2-amminotetraline-6,7 sostituite per la preparazione di composizioni farmaceutiche atte al trattamento di patologie |
PCT/IT1998/000250 WO1999015160A2 (en) | 1997-09-22 | 1998-09-18 | Use of 6,7-substituted 2-aminotetralines suitable for preparing pharmaceutical composition for the therapeutic treatment of inflammatory and/or autoimmune pathologies |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69802828D1 true DE69802828D1 (de) | 2002-01-17 |
DE69802828T2 DE69802828T2 (de) | 2002-07-18 |
Family
ID=11405258
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69802828T Expired - Fee Related DE69802828T2 (de) | 1997-09-22 | 1998-09-18 | Verwendung von 6,7-substituierter 2-aminotetraline zur behandlung von zytokin-vermittleten entzündungszuständen |
Country Status (17)
Country | Link |
---|---|
US (1) | US6242497B1 (de) |
EP (1) | EP1017377B1 (de) |
JP (1) | JP2001517618A (de) |
KR (1) | KR20010030670A (de) |
CN (1) | CN1276721A (de) |
AT (1) | ATE209910T1 (de) |
AU (1) | AU735369B2 (de) |
BR (1) | BR9812489A (de) |
CA (1) | CA2303918A1 (de) |
DE (1) | DE69802828T2 (de) |
DK (1) | DK1017377T3 (de) |
ES (1) | ES2167942T3 (de) |
IT (1) | IT1294932B1 (de) |
MX (1) | MXPA00002774A (de) |
NZ (1) | NZ503391A (de) |
PT (1) | PT1017377E (de) |
WO (1) | WO1999015160A2 (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1294931B1 (it) * | 1997-09-22 | 1999-04-23 | Sigma Tau Ind Farmaceuti | Derivati della 2-amminotetralina procedimento per la loro preparazione e composizioni farmaceutiche che li contengono, attive nella |
WO2011047350A2 (en) * | 2009-10-16 | 2011-04-21 | David Helton | Emesis treatment |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1241988B (it) * | 1990-06-15 | 1994-02-02 | Sigma Tau Ind Farmaceuti | 2- amminotetraline-6, 7-sostituite attive come immunomodulanti e composizioni farmaceutiche che le contengono |
IT1278045B1 (it) * | 1995-03-09 | 1997-11-17 | Sigma Tau Ind Farmaceuti | Uso di 2-amminotetraline-6,7-sostituite per la preparazione di composizioni farmaceutiche atte al trattamento dello shock, e di |
-
1997
- 1997-09-22 IT IT97RM000569A patent/IT1294932B1/it active IP Right Grant
-
1998
- 1998-09-18 JP JP2000512530A patent/JP2001517618A/ja active Pending
- 1998-09-18 DK DK98946704T patent/DK1017377T3/da active
- 1998-09-18 BR BR9812489-7A patent/BR9812489A/pt not_active IP Right Cessation
- 1998-09-18 ES ES98946704T patent/ES2167942T3/es not_active Expired - Lifetime
- 1998-09-18 CN CN98810460A patent/CN1276721A/zh active Pending
- 1998-09-18 CA CA002303918A patent/CA2303918A1/en not_active Abandoned
- 1998-09-18 DE DE69802828T patent/DE69802828T2/de not_active Expired - Fee Related
- 1998-09-18 NZ NZ503391A patent/NZ503391A/en unknown
- 1998-09-18 AT AT98946704T patent/ATE209910T1/de not_active IP Right Cessation
- 1998-09-18 AU AU93661/98A patent/AU735369B2/en not_active Ceased
- 1998-09-18 MX MXPA00002774A patent/MXPA00002774A/es unknown
- 1998-09-18 WO PCT/IT1998/000250 patent/WO1999015160A2/en not_active Application Discontinuation
- 1998-09-18 EP EP98946704A patent/EP1017377B1/de not_active Expired - Lifetime
- 1998-09-18 PT PT98946704T patent/PT1017377E/pt unknown
- 1998-09-18 KR KR1020007003076A patent/KR20010030670A/ko not_active Application Discontinuation
-
2000
- 2000-03-22 US US09/533,066 patent/US6242497B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
NZ503391A (en) | 2001-06-29 |
BR9812489A (pt) | 2000-09-26 |
US6242497B1 (en) | 2001-06-05 |
ES2167942T3 (es) | 2002-05-16 |
EP1017377B1 (de) | 2001-12-05 |
PT1017377E (pt) | 2002-04-29 |
ATE209910T1 (de) | 2001-12-15 |
KR20010030670A (ko) | 2001-04-16 |
MXPA00002774A (es) | 2002-10-31 |
WO1999015160A2 (en) | 1999-04-01 |
DE69802828T2 (de) | 2002-07-18 |
AU9366198A (en) | 1999-04-12 |
IT1294932B1 (it) | 1999-04-23 |
ITRM970569A1 (it) | 1999-03-22 |
CN1276721A (zh) | 2000-12-13 |
EP1017377A2 (de) | 2000-07-12 |
CA2303918A1 (en) | 1999-04-01 |
AU735369B2 (en) | 2001-07-05 |
DK1017377T3 (da) | 2002-03-04 |
WO1999015160A3 (en) | 1999-05-20 |
JP2001517618A (ja) | 2001-10-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE225176T1 (de) | Verwendung von serotonin-antagonisten (5ht3) zur behandlung von fibromyalgie | |
ATE241358T1 (de) | Verwendung von cholinesterasehemmer zur behandlung von konzentrationsstörungen | |
ATE279181T1 (de) | Verwendung von 5ht-6 antagonisten zur behandlung adhd | |
DE69724016D1 (de) | Verwendung von anti-mikrotubuli mitteln zur behandlung von entzündlichen erkrankungen der atemwege | |
DE69726724D1 (de) | Tetrahydropteridine und pyridylpiperazine zur behandlung von neurologischen störungen | |
DE59611411D1 (de) | Verwendung von alpha 1l-agonisten zur behandlung der harninkontinenz | |
DE60015070D1 (de) | Verwendung von antikonvulsiven derivaten zur behandlung der cluster headache | |
EA199800667A1 (ru) | Новые фенантридины | |
ATE194593T1 (de) | 3-(3,4-dioxyphenyl)-pyrrolidine als inhibitonen der typ iv - phosphodiesterase zur behandlung von entzündungskrankheiten | |
DE59310137D1 (de) | Verwendung von substituierten Benzimidazolen zur Bekämpfung parasitärer Protozoen | |
DE69929041D1 (de) | Verwendung von cabergolin zur behandlung von "restless legs syndrom" | |
DK0889886T5 (da) | Hidtil ukendte, i 6-stilling substituerede phenanthridiner | |
MX9302011A (es) | Derivados de indol. | |
ATE311853T1 (de) | Verwendung von krillenzymen zur behandlung von zahnbelag | |
DE59707519D1 (de) | Verwendung von 1-hydroxy-2-pyridonen zur behandlung von hautinfektionen | |
ATE210447T1 (de) | Verwendung von cck-b rezeptor antagonisten zur behandlung von schlafstörungen | |
ATE209891T1 (de) | Verwendung von 1-hydroxy-2-pyridonen zur behandlung der seborrhoischen dermatitis | |
ATE234614T1 (de) | Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren | |
DE69802828D1 (de) | Verwendung von 6,7-substituierter 2-aminotetraline zur behandlung von zytokin-vermittleten entzündungszuständen | |
ATE333869T1 (de) | Verwendung von mglur5 antagonisten zur behandlung von pruritischen zuständen | |
DE69701458T2 (de) | Verwendung von buckminsterfulleren zur behandlung neurotoxischer verletzungen | |
DE69429013D1 (de) | Verwendung von dimeticon zur behandlung der konstipation | |
TR199700416A2 (xx) | Fluorinlenmi� vitamin D3 analoglar�. | |
DE3778158D1 (de) | Inhibitoren von esterase produzierenden mikroorganismen zur hauptverwendung in deodorants. | |
DE69936779D1 (de) | Verwendung von ngali nussöl zur behandlung/linderung der arthritisschmerzen und anderer ähnlichen störungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |